Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.

ABSTRACT: The goal of our study is to investigate the contribution of promoter DNA methylation of ?-adducin (ADD1) gene to the risk of essential hypertension (EH). Using the bisulphite pyrosequencing technology, DNA methylation levels of five CpG dinucleotides on ADD1 promoter were measured among 33 EH cases and 28 healthy controls. Significantly higher ADD1 DNA methylation levels were observed in the females than in the males (CpG1: P?=?0.016; CpG2-5: P?=?0.021). A breakdown analysis by gender showed that lower CpG1 methylation was associated with an increased risk of EH in females (adjusted P?=?0.042). A much more significant association between lower CpG2-5 methylation levels and the increased risk of EH was found in males (adjusted P?=?0.008). CpG1 methylation was inversely correlated with age in females (r?=?-0.407, P?=?0.019) but not in males. ADD1 CpG1 and CpG2-5 methylation levels were significantly lower in post-menopausal (>50 years) women than pre-menopausal (?50 years) women (CpG1: P?=?0.006; CpG2-5: P?=?0.034). A significant interaction between CpG1 methylation and age was found in females (CpG1*age: P?=?0.029). CpG2-5 methylation was shown as a significant predictor of EH in males [area under curve (AUC)?=?0.855, P?=?0.001], in contrast that CpG1 methylation was a trend toward indicator in females (AUC?=?0.699, P?=?0.054). In addition, significant differences were observed between males and females for alanine aminotransferase (ALT, P?=?0.001), aspartate aminotransferase (AST, P?=?0.005) and uric acid (P<0.001). The concentration of AST was inversely correlated with ADD1 CpG2-5 methylation levels in female controls (r?=?-0.644, P?=?0.024). These observations may bring new hints to elaborate the pathogenesis of EH.

SUBMITTER: Zhang LN 

PROVIDER: S-EPMC3655193 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature